癌症早筛公司GRAIL昨天宣布,获得由ARCH Venture Partners和Johnson & Johnson Innovation联合领投第一波B轮融资,GRAIL已经拿到超过9亿美元。此外,Amazon, Bristol-Myers Squibb, Celgene, McKesson Ventures, Merck,Tencent Holdings Limited 和Varian Medical Systems跟投。据悉,第二波的B轮融资正在计划开启中,这一波完成之后,GRAIL将收获超10亿美元的超级B轮融资。原文链接